Source: InnovationNews

InDevR: InDevR expands commercial portfolio for coronavirus vaccine characterization

BOULDER -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Kathy Rowlen's photo - Co-Founder & CEO of InDevR

Co-Founder & CEO

Kathy Rowlen

CEO Approval Rating

82/100

Read more